BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 26281945)

  • 1. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
    Xiang Y; Song X; Long D
    Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.
    Milani P; Ambrosi G; Gammoh O; Blandini F; Cereda C
    Oxid Med Cell Longev; 2013; 2013():836760. PubMed ID: 23983902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WDR23 mediates NRF2 proteostasis and cytoprotective capacity in the hippocampus.
    Liu J; Duangjan C; Irwin RW; Curran SP
    Mech Ageing Dev; 2024 Apr; 218():111914. PubMed ID: 38301772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress and the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Pathway in Multiple Sclerosis: Focus on Certain Exogenous and Endogenous Nrf2 Activators and Therapeutic Plasma Exchange Modulation.
    Tonev D; Momchilova A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
    Chiurchiù V; Orlacchio A; Maccarrone M
    Oxid Med Cell Longev; 2016; 2016():7909380. PubMed ID: 26881039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-based therapeutics in neurodegenerative disease.
    McBean GJ; López MG; Wallner FK
    Br J Pharmacol; 2017 Jun; 174(12):1750-1770. PubMed ID: 27477685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases.
    Saha S; Buttari B; Profumo E; Tucci P; Saso L
    Front Cell Neurosci; 2021; 15():787258. PubMed ID: 35126058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRF2 as a Therapeutic Target in Neurodegenerative Diseases.
    Brandes MS; Gray NE
    ASN Neuro; 2020; 12():1759091419899782. PubMed ID: 31964153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating NRF2 in Disease: Timing Is Everything.
    Dodson M; de la Vega MR; Cholanians AB; Schmidlin CJ; Chapman E; Zhang DD
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():555-575. PubMed ID: 30256716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.
    Sbodio JI; Snyder SH; Paul BD
    Antioxid Redox Signal; 2019 Apr; 30(11):1450-1499. PubMed ID: 29634350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Traditional Chinese medicine used as anti-aging agent by targeting nuclear factor erythroid 2-related factor 2 signaling pathway].
    Xu JY; Yan LW; Tang SK; Liu PF
    Sheng Li Xue Bao; 2023 Dec; 75(6):877-886. PubMed ID: 38151350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Curcumin on Astrocytes in Common Neurodegenerative Conditions.
    Alameri AA; Ghanni MU; Ali A; Singh M; Al-Gazally ME; Almulla AF; Alexis Ramírez-Coronel A; Mustafa YF; Gupta R; Obaid RF; Gabr GA; Farhood B
    Mini Rev Med Chem; 2023; 23(22):2117-2129. PubMed ID: 37132107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
    Bhullar KS; Rupasinghe HP
    Oxid Med Cell Longev; 2013; 2013():891748. PubMed ID: 23840922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Stress in Neurodegenerative Diseases.
    Niedzielska E; Smaga I; Gawlik M; Moniczewski A; Stankowicz P; Pera J; Filip M
    Mol Neurobiol; 2016 Aug; 53(6):4094-4125. PubMed ID: 26198567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets.
    Basagni F; Di Paolo ML; Cozza G; Dalla Via L; Fagiani F; Lanni C; Rosini M; Minarini A
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox regulation of autophagy in healthy brain and neurodegeneration.
    Hensley K; Harris-White ME
    Neurobiol Dis; 2015 Dec; 84():50-9. PubMed ID: 25771170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Role of Oxidative Stress in the Pathophysiology of Neurodegenerative Disorders.
    Singh S; Ahuja A; Pathak S
    Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38243956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases.
    Scarian E; Viola C; Dragoni F; Di Gerlando R; Rizzo B; Diamanti L; Gagliardi S; Bordoni M; Pansarasa O
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates.
    Martínez A; Portero-Otin M; Pamplona R; Ferrer I
    Brain Pathol; 2010 Mar; 20(2):281-97. PubMed ID: 19725834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.